At Focal Biosciences, we are building a platform and pipeline to reprogram cells to a healthier state and deliver disease modifying medicines against chronic diseases.
Our core technology, the CFC (Chromatin Fingerprint for Cell state)-Platform, epitomizes a new approach to reprogramming cells, distinguished by speed, breadth, and an AI-enhanced approach to provide unique insights into complex biological processes. We believe that biology cannot be solved with limited datasets and narrow perspectives.
We're redefining drug discovery by searching for drugs that not only
slow down disease progression but actually reprogram cells at the
chromatin level to
Our approach is not only superior, but also can be used to investigate age-related diseases across a range of human tissues, thanks to our tissue-mimicking disease models and machine learning.
Our immediate focus lies in addressing fibrotic diseases, but our vision encompasses a broader range of age-related chronic diseases. We’re not just aiming to treat diseases; we’re striving to reverse and cure them.
We invite industry leaders and innovators to collaborate with us in this transformative journey and be part of a groundbreaking shift in targeting diseases through reprogramming.Join us
Together, we will make a significant impact on drug discovery for patients globally, transforming the way we think about treating diseases.
Chief Operations Officer
Chief Data Officer
Head of R&D
Head of Technology
For more information about partnering or investment inquiries, please get in touch.Contact us